ARTICLE | Clinical News
Neutralase heparin degrading enzyme: Phase II
September 30, 1996 7:00 AM UTC
Ibex Technologies Inc. (TSE:IBT), Montreal, Quebec Product: Neutralase heparin degrading enzyme (heparinase I) Use: Replace protamine as a heparin neutralizer after cardiac bypass surgery Status: IBT ...